The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics
Open accessAbstract
The coronavirus outbreak emerged as a severe pandemic, claiming more than 0.8 million lives across the world and raised a major global health concern. We survey the history and mechanism of coronaviruses, and the structural characteristics of the spike protein and its key residues responsible for human transmissions. We have carried out a systematic review to summarize the origin, transmission and etiology of COVID-19. The structural analysis of the spike protein and its disordered residues explains the mechanism of the viral transmission. A meta-data analysis of the therapeutic compounds targeting the SARS-CoV-2 is also included. Coronaviruses can cross the species barrier and infect humans with unexpected consequences for public health. The transmission rate of SARS-CoV-2 infection is higher compared to that of the closely related SARS-CoV infections. In SARS-CoV-2 infection, intrinsically disordered regions are observed at the interface of the spike protein and ACE2 receptor, providing a shape complementarity to the complex. The key residues of the spike protein have stronger binding affinity with ACE2. These can be probable reasons for the higher transmission rate of SARS-CoV-2. In addition, we have also discussed the therapeutic compounds and the vaccines to target SARS-CoV-2, which can help researchers to develop effective drugs/vaccines for COVID-19. The overall history and mechanism of entry of SARS-CoV-2 along with structural study of spike-ACE2 complex provide insights to understand disease pathogenesis and development of vaccines and drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · cited 3×
“The ectodomain of the SARS-CoV-2 spike protein binds to the peptidase domain (PD) of ACE2 with a Kd (equilibrium dissociation constant) of ~ 15 nM [4].”
BackgroundInfluentialInhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“SARS-CoV-2 uses ACE2, a cell-surface receptor that is present in the kidney, blood vessels, heart, and importantly, in the lung AT2 alveolar respiratory tract epithelial cells for viral infection [18].”
BackgroundStructural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 7×
“Until the first identification of human coronaviruses 229E and OC43, in the late 1960s, coronavirus infections were witnessed as harmless for humans [14, 15].”
BackgroundInfluentialTransmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Janke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,144
Intrinsically unstructured proteins and their functions
Dyson, H. J., & Wright, P. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1589 · Cited by 3,871
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109 · cited 8×
“During the initial phase of the COVID-19 outbreak, a dataset was obtained from 1099 patients with laboratoryconfirmed COVID-19 from 552 hospitals in 30 provinces of China on January 29, 2020.”
BackgroundInfluentialStructural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Wang, Q., Zhang, Y., Wu, L., Niu, S., Song, C., Zhang, Z., Lu, G., Qiao, C., Hu, Y., Yuen, K.-Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.045 · Cited by 2,892 · cited 1×
“Specifically, the regions, Leu455 to Pro491 and Asn501 to Val503 show disorder-to-order transitions [61].”
BackgroundStructure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
The COVID-19 vaccine development landscape
Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,954
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,811
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., & Decroly, E. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,679
Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., & Hidaka, H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34116-x · Cited by 1,484
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30304-4 · Cited by 1,456
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
Zhu, H., Wang, L., Fang, C., Peng, S., Zhang, L., Chang, G., Xia, S., & Zhou, W. (2020) · Translational Pediatrics · doi:10.21037/tp.2020.02.06 · Cited by 1,426
Return of the Coronavirus: 2019-nCoV
Gralinski, L. E., & Menachery, V. D. (2020) · Viruses · doi:10.3390/v12020135 · Cited by 1,348
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance
Phelan, A. L., Katz, R., & Gostin, L. O. (2020) · JAMA · doi:10.1001/jama.2020.1097 · Cited by 1,207
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192
Severe acute respiratory syndrome
Peiris, J. S. M., Guan, Y., & Yuen, K. Y. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,139
SARS-CoV-2 Vaccines: Status Report
Amanat, F., & Krammer, F. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.007 · Cited by 1,120
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Zengerle, M., Chan, K.-H., & Ciulli, A. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00216 · Cited by 1,056
Hu, B., Zeng, L.-P., Yang, X.-L., Ge, X.-Y., Zhang, W., Li, B., Xie, J.-Z., Shen, X.-R., Zhang, Y.-Z., Wang, N., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006698 · Cited by 950
The Coronavirus Nucleocapsid Is a Multifunctional Protein
McBride, R., Van Zyl, M., & Fielding, B. (2014) · Viruses · doi:10.3390/v6082991 · Cited by 942
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Millet, J. K., & Whittaker, G. R. (2015) · Virus Research · doi:10.1016/j.virusres.2014.11.021 · Cited by 902
Crystal structure of the human angiotensin-converting enzyme–lisinopril complex
Natesh, R., Schwager, S. L. U., Sturrock, E. D., & Acharya, K. R. (2003) · Nature · doi:10.1038/nature01370 · Cited by 888
Pre-fusion structure of a human coronavirus spike protein
Kirchdoerfer, R. N., Cottrell, C. A., Wang, N., Pallesen, J., Yassine, H. M., Turner, H. L., Corbett, K. S., Graham, B. S., McLellan, J. S., & Ward, A. B. (2016) · Nature · doi:10.1038/nature17200 · Cited by 765
Graham, R. L., & Baric, R. S. (2010) · Journal of Virology · doi:10.1128/jvi.01394-09 · Cited by 751
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Khan, N., Jeffers, M., Kumar, S., Hackett, C., Boldog, F., Khramtsov, N., Qian, X., Mills, E., Berghs, S. C., Carey, N., et al. (2008) · Biochemical Journal · doi:10.1042/bj20070779 · Cited by 713
Wang, H., Yang, P., Liu, K., Guo, F., Zhang, Y., Zhang, G., & Jiang, C. (2008) · Cell Research · doi:10.1038/cr.2008.15 · Cited by 707
Stevenson, G. W., Hoang, H., Schwartz, K. J., Burrough, E. R., Sun, D., Madson, D., Cooper, V. L., Pillatzki, A., Gauger, P., Schmitt, B. J., et al. (2013) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/1040638713501675 · Cited by 704
Setti, L., Passarini, F., De Gennaro, G., Barbieri, P., Perrone, M. G., Borelli, M., Palmisani, J., Di Gilio, A., Piscitelli, P., & Miani, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17082932 · Cited by 670
Gui, M., Song, W., Zhou, H., Xu, J., Chen, S., Xiang, Y., & Wang, X. (2017) · Cell Research · doi:10.1038/cr.2016.152 · Cited by 589
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
Li, F. (2015) · Journal of Virology · doi:10.1128/jvi.02615-14 · Cited by 573
The SARS coronavirus nucleocapsid protein – Forms and functions
Chang, C.-K., Hou, M.-H., Chang, C.-F., Hsiao, C.-D., & Huang, T.-H. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2013.12.009 · Cited by 529
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg315 · Cited by 523
Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F., & Matsuyama, S. (2012) · Journal of Virology · doi:10.1128/jvi.00094-12 · Cited by 515
Siddiqui-Jain, A., Drygin, D., Streiner, N., Chua, P., Pierre, F., O'Brien, S. E., Bliesath, J., Omori, M., Huser, N., Ho, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1893 · Cited by 506
Coronavirus Replication Complex Formation Utilizes Components of Cellular Autophagy
Prentice, E., Jerome, W. G., Yoshimori, T., Mizushima, N., & Denison, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306124200 · Cited by 450
Consideration of the Aerosol Transmission for COVID-19 and Public Health
Anderson, E. L., Turnham, P., Griffin, J. R., & Clarke, C. C. (2020) · Risk Analysis · doi:10.1111/risa.13500 · Cited by 433
Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1752802 · Cited by 415
Self-citationSimmons, G., Zmora, P., Gierer, S., Heurich, A., & Pöhlmann, S. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.028 · Cited by 413
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
Yang, N., & Shen, H.-M. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45498 · Cited by 412
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
Faivre, E. J., McDaniel, K. F., Albert, D. H., Mantena, S. R., Plotnik, J. P., Wilcox, D., Zhang, L., Bui, M. H., Sheppard, G. S., Wang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-1930-8 · Cited by 408
Shah, P. S., Link, N., Jang, G. M., Sharp, P. P., Zhu, T., Swaney, D. L., Johnson, J. R., Von Dollen, J., Ramage, H. R., Satkamp, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.028 · Cited by 380
Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission
Somsen, G. A., van Rijn, C., Kooij, S., Bem, R. A., & Bonn, D. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30245-9 · Cited by 379
Huang, I.-C., Bosch, B. J., Li, F., Li, W., Lee, K. H., Ghiran, S., Vasilieva, N., Dermody, T. S., Harrison, S. C., Dormitzer, P. R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508381200 · Cited by 375
Structural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike protein
Hussain, M., Jabeen, N., Raza, F., Shabbir, S., Baig, A. A., Amanullah, A., & Aziz, B. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25832 · Cited by 354
SARS-CoV Infection in a Restaurant from Palm Civet
Wang, M., Yan, M., Xu, H., Liang, W., Kan, B., Zheng, B., Chen, H., Zheng, H., Xu, Y., Zhang, E., et al. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1112.041293 · Cited by 347
Yamamoto, M., Matsuyama, S., Li, X., Takeda, M., Kawaguchi, Y., Inoue, J.-I., & Matsuda, Z. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01043-16 · Cited by 340
Chiu, S. S., Hung Chan, K., Wing Chu, K., Kwan, S. W., Guan, Y., Man Poon, L. L., & Peiris, J. S. M. (2005) · Clinical Infectious Diseases · doi:10.1086/430301 · Cited by 325
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
Uddin, M., Mustafa, F., Rizvi, T. A., Loney, T., Al Suwaidi, H., Al-Marzouqi, A. H. H., Kamal Eldin, A., Alsabeeha, N., Adrian, T. E., Stefanini, C., et al. (2020) · Viruses · doi:10.3390/v12050526 · Cited by 319
Xia, S., Lan, Q., Su, S., Wang, X., Xu, W., Liu, Z., Zhu, Y., Wang, Q., Lu, L., & Jiang, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0184-0 · Cited by 312
Pierre, F., Chua, P. C., O’Brien, S. E., Siddiqui-Jain, A., Bourbon, P., Haddach, M., Michaux, J., Nagasawa, J., Schwaebe, M. K., Stefan, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101251q · Cited by 296
Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1754293 · Cited by 293
Receptor recognition and cross-species infections of SARS coronavirus
Li, F. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.014 · Cited by 268
Huang, X., Dong, W., Milewska, A., Golda, A., Qi, Y., Zhu, Q. K., Marasco, W. A., Baric, R. S., Sims, A. C., Pyrc, K., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00854-15 · Cited by 261
Translation control of the immune checkpoint in cancer and its therapeutic targeting
Xu, Y., Poggio, M., Jin, H. Y., Shi, Z., Forester, C. M., Wang, Y., Stumpf, C. R., Xue, L., Devericks, E., So, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0321-2 · Cited by 261
And the MIRACLE trial group, Arabi, Y. M., Alothman, A., Balkhy, H. H., Al-Dawood, A., AlJohani, S., Al Harbi, S., Kojan, S., Al Jeraisy, M., Deeb, A. M., et al. (2018) · Trials · doi:10.1186/s13063-017-2427-0 · Cited by 253
Structural insight into allosteric modulation of protease-activated receptor 2
Cheng, R. K. Y., Fiez-Vandal, C., Schlenker, O., Edman, K., Aggeler, B., Brown, D. G., Brown, G. A., Cooke, R. M., Dumelin, C. E., Doré, A. S., et al. (2017) · Nature · doi:10.1038/nature22309 · Cited by 246
Structure of the N-Terminal RNA-Binding Domain of the SARS CoV Nucleocapsid Protein
Huang, Q., Yu, L., Petros, A. M., Gunasekera, A., Liu, Z., Xu, N., Hajduk, P., Mack, J., Fesik, S. W., & Olejniczak, E. T. (2004) · Biochemistry · doi:10.1021/bi036155b · Cited by 244
Asano, N., Ishii, S., Kizu, H., Ikeda, K., Yasuda, K., Kato, A., Martin, O. R., & Fan, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01457.x · Cited by 242
Cellular entry of the SARS coronavirus
Hofmann, H., & Pöhlmann, S. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.08.008 · Cited by 237
Yazdany, J., & Kim, A. H. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1334 · Cited by 236
SARS coronavirus: a new challenge for prevention and therapy
Holmes, K. V. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18819 · Cited by 223
Leroy, E. M., Ar Gouilh, M., & Brugère-Picoux, J. (2020) · One Health · doi:10.1016/j.onehlt.2020.100133 · Cited by 219
Albrecht, B. K., Gehling, V. S., Hewitt, M. C., Vaswani, R. G., Côté, A., Leblanc, Y., Nasveschuk, C. G., Bellon, S., Bergeron, L., Campbell, R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01882 · Cited by 212
RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
McLure, K. G., Gesner, E. M., Tsujikawa, L., Kharenko, O. A., Attwell, S., Campeau, E., Wasiak, S., Stein, A., White, A., Fontano, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083190 · Cited by 198
SARS-coronavirus replication in human peripheral monocytes/macrophages
Yilla, M., Harcourt, B. H., Hickman, C. J., McGrew, M., Tamin, A., Goldsmith, C. S., Bellini, W. J., & Anderson, L. J. (2005) · Virus Research · doi:10.1016/j.virusres.2004.09.004 · Cited by 190
The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?
Abassi, Z., Knaney, Y., Karram, T., & Heyman, S. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01312 · Cited by 179
Porcine respiratory coronavirus: molecular features and virus-host interactions.
Laude, H., Reeth, K. V., & Pensaert, M. B. (1993) · PubMed · Cited by 177
Reich, S. H., Sprengeler, P. A., Chiang, G. G., Appleman, J. R., Chen, J., Clarine, J., Eam, B., Ernst, J. T., Han, Q., Goel, V. K., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01795 · Cited by 175
Nissinen, E., Lindén, I., Schultz, E., & Pohto, P. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00173538 · Cited by 166
Díaz, J. L., Cuberes, R., Berrocal, J., Contijoch, M., Christmann, U., Fernández, A., Port, A., Holenz, J., Buschmann, H., Laggner, C., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3007323 · Cited by 147
Hodgson, J. (2020) · Nature Biotechnology · doi:10.1038/d41587-020-00005-z · Cited by 145
ATP-Competitive Inhibitors of mTOR: An Update
Schenone, S., Brullo, C., Musumeci, F., Radi, M., & Botta, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391651 · Cited by 142
Deadly pig virus slips through US borders
Mole, B. (2013) · Nature · doi:10.1038/499388a · Cited by 138
Meyer, D., Sielaff, F., Hammami, M., Böttcher‐Friebertshäuser, E., Garten, W., & Steinmetzer, T. (2013) · Biochemical Journal · doi:10.1042/bj20130101 · Cited by 130
Mycophenolic Acid: an Anti-cancer Compound with Unusual Properties
CARTER, S. B., Franklin, T. J., Jones, D., LEONARD, B. J., MILLS, S. D., Turner, R., & Turner, W. B. (1969) · Nature · doi:10.1038/223848a0 · Cited by 122
Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis
Nagiec, E. E., Wu, L., Swaney, S. M., Chosay, J. G., Ross, D., Brieland, J. K., & Leach, K. L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3896-3902.2005 · Cited by 120
Xu, L., Chen, Y., Mayakonda, A., Koh, L., Chong, Y. K., Buckley, D. L., Sandanaraj, E., Lim, S. W., Lin, R. Y., Ke, X., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712363115 · Cited by 117
Novel Agonists and Antagonists for Human Protease Activated Receptor 2
Barry, G. D., Suen, J. Y., Le, G. T., Cotterell, A. J., Reid, R. C., & Fairlie, D. P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100984y · Cited by 115
Azzariti, A., Colabufo, N. A., Berardi, F., Porcelli, L., Niso, M., Simone, G. M., Perrone, R., & Paradiso, A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0402 · Cited by 112
Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment
Pu, S., Xiao, F., Schor, S., Bekerman, E., Zanini, F., Barouch‐Bentov, R., Nagamine, C. M., & Einav, S. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.05.001 · Cited by 110
Blocking eIF4E-eIF4G Interaction as a Strategy To Impair Coronavirus Replication
Cencic, R., Desforges, M., Hall, D. R., Kozakov, D., Du, Y., Min, J., Dingledine, R. J., Fu, H., Vajda, S., Talbot, P. J., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00078-11 · Cited by 108
Short-Chain HDAC Inhibitors Differentially Affect Vertebrate Development and Neuronal Chromatin
Fass, D. M., Shah, R. R., Ghosh, B., Hennig, K. M., Norton, S., Zhao, W., Reis, S. A., Klein, P. S., Mazitschek, R., Maglathlin, R. L., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1001954 · Cited by 90
Discovery of XL413, a potent and selective CDC7 inhibitor
Koltun, E. S., Tsuhako, A. L., Brown, D. S., Aay, N., Arcalas, A., Chan, V., Du, H., Engst, S., Ferguson, K., Franzini, M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.024 · Cited by 87
Mackman, R. L., Steadman, V. A., Dean, D. K., Jansa, P., Poullennec, K. G., Appleby, T. C., Austin, C., Blakemore, C. A., Cai, R. Z., Cannizzaro, C. E., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00802 · Cited by 79
Asymptomatic carriage and transmission of SARS-CoV-2: What do we know?
Lee, S. M., Meyler, P., Mozel, M., Tauh, T., & Merchant, R. N. (2020) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01729-x · Cited by 78
Protein intrinsic disorder and influenza virulence: the 1918 H1N1 and H5N1 viruses
Goh, G. K., Dunker, A. K., & Uversky, V. N. (2009) · Virology Journal · doi:10.1186/1743-422x-6-69 · Cited by 77
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships
Leung, L. M. H., Niculescu‐Duvaz, D., Smithen, D. A., Lopes, F., Callens, C., McLeary, R., Saturno, G., Davies, L. C., Aljarah, M., Brown, M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00335 · Cited by 77
Priebe, W., Krawczyk, M., Kuo, M. T., YAMANE, Y., Savaraj, N., & Ishikawa, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8887 · Cited by 74
Rutaganira, F. U., Fowler, M. L., McPhail, J. A., Gelman, M. A., Nguyen, K., Xiong, A., Dornan, G. L., Tavshanjian, B., Glenn, J. S., Shokat, K. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01311 · Cited by 72
Tesei, A., Cortesi, M., Zamagni, A., Arienti, C., Pignatta, S., Zanoni, M., Paolillo, M., Curti, D., Rui, M., Rossi, D., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00711 · Cited by 72
(R)- and (S)-Verapamil Differentially Modulate the Multidrug-resistant Protein MRP1
Perrotton, T., Trompier, D., Chang, X.-B., Pietro, A. D., & Baubichon-Cortay, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703964200 · Cited by 70
Severity and Outcome Associated With Human Coronavirus OC43 Infections Among Children
Jean, A., Quach, C., Yung, A., & Semret, M. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182812787 · Cited by 65
Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease
Virant, M. J., Uršič, T., Žigon, N., Lusa, L., Krivec, U., & Petrovec, M. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-365 · Cited by 62
Carelli, J. D., Sethofer, S. G., Smith, G. A., Miller, H., Simard, J. L., Merrick, W. C., Jain, R. K., Ross, N. T., & Taunton, J. (2015) · eLife · doi:10.7554/elife.10222 · Cited by 60
IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex
Pua, K. H., Stiles, D. T., Sowa, M. E., & Verdine, G. L. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.030 · Cited by 58
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1
Llona‐Minguez, S., Höglund, A., Jacques, S. A., Johansson, L., Calderón‐Montaño, J. M., Claesson, M., Loseva, O., Valerie, N. C. K., Lundbäck, T., Piedrafita, F. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01741 · Cited by 53
McIver, E. G., Bryans, J. S., Birchall, K., Chugh, J., Drake, T., Lewis, S. J., Osborne, J., Smiljanic-Hurley, E., Tsang, W., Kamal, A. M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.063 · Cited by 51
The Pharmacology of the Novel and Selective Sigma Ligand, PD 144418
Akunne, H. C., Whetzel, S. Z., Wiley, J. N., Corbin, A., Ninteman, F. W., Tecle, H., PEI, Y., Pugsley, T. A., & Heffner, T. G. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(96)00161-x · Cited by 50
Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition
Phadke, M. A., Rix, L. L. R., Smalley, I., Bryant, A. T., Luo, Y., Lawrence, H. R., Schaible, B., Chen, Y. A., Rix, U., & Smalley, K. S. M. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12152 · Cited by 49
Jorquera, P. A., Mathew, C., Pickens, J. A., Williams, C., Luczo, J. M., Tamir, S., Ghildyal, R., & Tripp, R. A. (2018) · Journal of Virology · doi:10.1128/jvi.01684-18 · Cited by 47
Santi, C. D., Giulianotti, P. C., Pietrabissa, A., Mosca, F., & Pacifici, G. M. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050448 · Cited by 46
Toral‐Barza, L., Zhang, W., Lamison, C., LaRocque, J., Gibbons, J. J., & Yu, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.117 · Cited by 39
Discovery of Potent and Selective Small-Molecule PAR-2 Agonists
Seitzberg, J. G., Knapp, A. E., Lund, B. W., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800754r · Cited by 39
Novel Sigma Receptor Ligands: Synthesis and Biological Profile
Prezzavento, O., Campisi, A., Ronsisvalle, S., Volti, G. L., Marrazzo, A., Bramanti, V., Cannavò, G., Vanella, L., Cagnotto, A., Mennini, T., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0611197 · Cited by 35
Ma, J., Zhang, X., Soloveva, V., Warren, T. K., Guo, F., Wu, S., Lu, H., Guo, J., Su, Q., Shen, H. L., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.008 · Cited by 34
Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1
Llona‐Minguez, S., Höglund, A., Wiita, E., Almlöf, I., Mateus, A., Calderón‐Montaño, J. M., Cázares-Körner, C., Homan, E. J., Loseva, O., Baranczewski, P., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01786 · Cited by 27
LARP1 is a major phosphorylation substrate of mTORC1Preprint
Fonseca, B. D., Jia, J.-J., Hollensen, A. K., Pointet, R., Hoang, H., Niklaus, M., Pena, I. A., Lahr, R. M., Smith, E. M., Hearnden, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/491274 · Cited by 11
Thompson, P. A., Eam, B., Young, N. P., Fish, S., Chen, J. W., Barrera, M., Howard, H., Sung, E., Parra, A., Staunton, J., et al. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-2698 · Cited by 5
Metadata
- Authors
- Yesudhas, D., Srivastava, A., & Gromiha, M. M.
- Venue
- Infection
- Published
- 2020-09-04
- Volume
- 49
- Issue
- 2
- Pages
- 199-213
- ISSN
- 0300-8126 (ISSN-L)
- 1439-0973
- OpenAlex
- W3081936186
- Cited by
- 270
- References
- 136
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.